SCHEMBL21609072

SCHEMBL21609072

Nc1noc2cccc(C(F)(F)F)c12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 13/20 0.50
FLT3 P36888 12/20 0.50
KIT P10721 11/20 0.50
AURKB Q96GD4 4/20 0.45
MET P08581 3/20 0.45
MAP4K4 O95819 2/20 0.45
PDGFRB P09619 2/20 0.45
PIM1 P11309 2/20 0.45
FGFR1 P11362 2/20 0.45
PDGFRA P16234 2/20 0.45
PRKACA P17612 2/20 0.45
LTK P29376 2/20 0.45
GRK5 P34947 2/20 0.45
CDK8 P49336 2/20 0.45
CDK7 P50613 2/20 0.45
CDK9 P50750 2/20 0.45
LIMK1 P53667 2/20 0.45
MAP2K1 Q02750 2/20 0.45
ACVR1 Q04771 2/20 0.45
MST1R Q04912 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17030757 0.82 KDR (0.50) KDRFLT3KITAURKBMET
SCHEMBL20963390 0.79 KDR (0.47) KDRFLT3KITAURKBMET
SCHEMBL15907820 0.79 KDR (0.47) KDRFLT3KITAURKBMET
SCHEMBL1781743 0.76 KDR (0.54) KDRFLT3KITAURKBMET
SCHEMBL3086613 0.75 KIT (0.34) KDRFLT3KITMETEPHX2
SCHEMBL2445430 0.75 KDR (0.58) KDRFLT3KITAURKBMET
SCHEMBL21660404 0.75 EPHX2 (0.49) KDRFLT3KITEPHX2
SCHEMBL5049132 0.74 KDR (0.43) KDRFLT3KITAURKBMET
Hydrochloric Acid SCHEMBL5103456 0.73 KDR (0.56) KDRFLT3KITAURKBMET
SCHEMBL6990623 0.72 FAAH (0.36) KDRFLT3KITEPHX2HRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260062393-A1 Compounds CTXT PTY LTD (AU) 2026-03-05 US disclosed
US-12365655-B2 Compounds CTXT PTY LTD (AU) 2025-07-22 US disclosed
CN-112334466-B Compounds of formula (I) CTXT私人有限公司 2025-05-30 CN disclosed
EP-4335439-A2 COMPOUNDS CTXT PTY LTD (AU) 2024-03-13 EP disclosed
EP-3810602-B1 COMPOUNDS CTXT PTY LTD (AU) 2023-11-01 EP disclosed
EP-3810602-B1 COMPOUNDS CTXT PTY LTD (AU) 2023-11-01 EP disclosed
CN-115551848-A Heterocyclic compounds for controlling invertebrate pests 巴斯夫欧洲公司 2022-12-30 CN disclosed
US-20220153710-A1 Compounds CTXT PTY LTD (AU) 2022-05-19 US disclosed
US-20220153710-A1 Compounds CTXT PTY LTD (AU) 2022-05-19 US disclosed
US-20200039945-A1 Compounds CTXT PTY LIMITED (AU) 2020-02-06 US disclosed
WO-2019243491-A1 COMPOUNDS CTXT PTY LIMITED (AU) 2019-12-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220153710-A1 Compounds SLC10A1, ABCB11, PCSK9 KDR 4509/4885FLT3 2102/4885KIT 520/4885
US-20200039945-A1 Compounds SLC10A1, ABCB11, PCSK9 KDR 4505/4885FLT3 2101/4885KIT 519/4885
US-20260062393-A1 Compounds SCN2B, ABCB11, SCN1B KDR 1022/4885FLT3 2336/4885KIT 2385/4885
US-12365655-B2 Compounds SLC10A1, ABCB11, PCSK9 KDR 4505/4885FLT3 2101/4885KIT 519/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.